Healthcare Digital October 2026 | Page 38

JIANGSU HENGRUI PHARMACEUTICALS
TOP 10 – BIO-PHARMACEUTICAL COMPANIES

07

WATCH NOW
More to discover: Hengrui medicine in the Basel area

JIANGSU HENGRUI PHARMACEUTICALS

R & D PIPELINE SIZE: 177 EMPLOYEES: 20,600
CHIEF DIGITAL & TECHNOLOGY OFFICER: CONRAD WANG
Jiangsu Hengrui Pharmaceuticals is China’ s largest pharmaceutical company by market value. Its strategy focuses on oncology, cardiovascular, metabolic diseases and immunology, with more than 400 ongoing clinical trials, including more than 20 international studies. The company operates 15 R & D centres across Asia, Europe, the US and Australia, supported by a global R & D workforce of more than 5,600 professionals. Increasingly, it out-licenses assets to Western partners including GSK and Bristol Myers Squibb as it expands its global footprint.
38 October 2026